Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial

Publication date: July 2020Source: The Lancet Haematology, Volume 7, Issue 7Author(s): Elias Jabbour, Guillaume Richard-Carpentier, Yuya Sasaki, Marina Konopleva, Keyur Patel, Kathryn Roberts, Zhaohui Gu, Feng Wang, Xuelin Huang, Koji Sasaki, Nicholas J Short, Nitin Jain, Farhad Ravandi, Naval G Daver, Tapan M Kadia, Yesid Alvarado, Courtney D DiNardo, Ghayas C Issa, Naveen Pemmaraju, Guillermo Garcia-Manero
Source: The Lancet Haematology - Category: Hematology Source Type: research